GEODE CAPITAL MANAGEMENT, LLC - PROTEON THERAPEUTICS INC ownership

PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 1 filers reported holding PROTEON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of PROTEON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$63,000
+57.5%
155,6890.0%0.00%
Q3 2019$40,000
-37.5%
155,6890.0%0.00%
Q2 2019$64,000
+300.0%
155,689
+381.4%
0.00%
Q1 2019$16,000
-89.0%
32,340
-50.0%
0.00%
Q4 2018$146,000
+131.7%
64,680
+100.0%
0.00%
Q3 2018$63,000
-20.3%
32,3400.0%0.00%
Q2 2018$79,000
-1.2%
32,3400.0%0.00%
Q1 2018$80,000
+31.1%
32,3400.0%0.00%
Q4 2017$61,000
-11.6%
32,340
-6.6%
0.00%
Q3 2017$69,000
+30.2%
34,6130.0%0.00%
Q2 2017$53,000
-19.7%
34,613
-9.0%
0.00%
Q1 2017$66,000
-7.0%
38,031
+1.2%
0.00%
Q4 2016$71,000
-79.5%
37,569
+0.8%
0.00%
Q3 2016$347,000
+16.4%
37,261
+0.2%
0.00%
Q2 2016$298,000
-15.1%
37,184
-18.1%
0.00%
Q1 2016$351,000
-47.0%
45,412
+6.3%
0.00%
Q4 2015$662,000
+14.3%
42,727
+2.5%
0.00%
Q3 2015$579,000
-19.9%
41,690
+3.0%
0.00%
Q2 2015$723,000
+171.8%
40,482
+76.8%
0.00%
Q1 2015$266,000
+133.3%
22,891
+108.3%
0.00%
Q4 2014$114,00010,9920.00%
Other shareholders
PROTEON THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Abingworth LLP 2,017,872$27,423,00016.02%
Monashee Investment Management LLC 77,102$1,072,0007.40%
Deer VII & Co. Ltd. 315,101$4,383,0004.15%
RA Capital Management 1,506,872$20,961,0003.01%
MPM ASSET MANAGEMENT LLC 983,381$13,679,0002.10%
Omega Fund Management, LLC 250,000$3,478,0001.96%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,343$17,601,0000.68%
Perceptive Advisors 550,000$7,650,0000.31%
TIVERTON ASSET MANAGEMENT LLC 375,000$5,216,0000.12%
Baker Brothers Advisors 274,617$3,820,0000.04%
View complete list of PROTEON THERAPEUTICS INC shareholders